State Ledger
Company profile

Amylyx Pharmaceuticals, Inc. CIK 1658551

Ticker
AMLX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, MA 02142
Fiscal year end
2025 (FY)
Market Data
Close
$27.04
Change
+$0.16
Change %
0.60%
Volume
63,420

AMLX · trading date Oct 14, 2026 · previous close $26.88 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$0
Net income
-$144.74M
Total assets
$332.65M
Total liabilities
$27.39M
Stockholders' equity
$305.26M
Cash & equivalents
$226.65M
Operating income
-$153.29M
Operating cash flow
-$123.34M
Capital expenditures
$138.0K

Fiscal year 2025, via 10-K filed 2026-03-03. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$123.48M
Free cash flow margin
—
Liabilities / assets
8.2%
Equity / assets
91.8%
CapEx / revenue
—
Operating cash flow / net income
0.85×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $0 -$144.74M $332.65M $27.39M $305.26M
2024 $87.37M -$301.74M $193.63M $28.87M $164.77M
2023 $380.79M $49.27M $517.45M $84.02M $433.43M
2022 $22.23M -$198.38M $391.45M $50.85M $340.61M
2021 $285.0K -$87.93M $105.61M $17.43M -$151.17M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-14
Financials filed via
Form 10-K
filed 2026-03-03

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Cambridge, MA 02142
55 CAMBRIDGE PARKWAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies